Exotic Laboratories Pvt Ltd
About Exotic Laboratories Pvt Ltd
Data last updated:
Exotic Laboratories Pvt Ltd is a private limited company based in Vadodara, Gujarat, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 16 April 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1993PTC019298. Its GSTIN is 24AAACE4125F1Z8 (Gujarat).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Dharmisthaben Janardan Pandya (Whole-Time Director) and Jaymit Girish Bakshi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 1 Krishna Park Near. Mothers School Gotri, Vadodara, Gujarat, India – 390021.
As per the financials filed for FY 2025, the company reported a revenue of ₹31 Lakh, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹10.86 Lakh (net margin 35%) and EBITDA of ₹11.62 Lakh (EBITDA margin 37.5%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 3% over five years.
The company has about 5 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹1.6 Cr on record. Court records list 8 cases involving the company, including 6 filed by the company and 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Exotic Laboratories Pvt Ltd's registered office is in Vadodara, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 1 Krishna Park Near. Mothers School Gotri, Vadodara, Gujarat, India – 390021
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Exotic Laboratories Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Exotic Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Exotic Laboratories Pvt Ltd
FY 2025 filings availableExotic Laboratories Pvt Ltd reported revenue of ₹31 Lakh (up 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 1% growth in the latest year. EBITDA fell 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.62 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.86 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 37.5% | ||||
| Net Profit Margin | 35% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Exotic Laboratories Pvt Ltd, buy the company report.
Board of directors of Exotic Laboratories Pvt Ltd
Exotic Laboratories has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dharmisthaben Janardan Pandya Also directs: Apcot Hospitals Private Limited | Whole-Time Director | 03 Mar 2014 | 12 Years 7 Months | Current |
| Jaymit Girish Bakshi Also directs: Apcot Hospitals Private Limited | Director | 05 Sep 2018 | 8 Years 1 Months | Current |
| Shilpica Girish Bakshi Also directs: Apcot Hospitals Private Limited | Director | 24 Dec 2019 | 6 Years 10 Months | Current |
Peer comparison
Exotic Laboratories Pvt Ltd is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Harmonic Cet Solutions Private Limited | ₹31.17 Lakh (FY 2022) | 156.0% | Hyderabad, Telangana, India | |||
| Kontiki Chemicals and Pharmaceuticals Pvt Ltd | ₹31.16 Lakh (FY 2025) | 5.0% | Kannur, Kerala, India | |||
| Guillain Pharma Private Limited | ₹31.13 Lakh (FY 2025) | 21.0% | Jamui, Bihar, India | |||
| Biostategi (OPC) Private Limited | ₹31.03 Lakh (FY 2025) | 105.0% | Kanpur, Uttar Pradesh, India | |||
| Valcambi Private Limited | ₹31.02 Lakh (FY 2025) | 32.0% | Manmad, Maharashtra, India | |||
| Exotic Laboratories Pvt Ltdthis company | ₹31 Lakh (FY 2025) | ₹10.86 Lakh | 35% | 1.0% | 5 | Vadodara, Gujarat, India |
| Yashil Enterprises (OPC) Private Limited | ₹30.95 Lakh (FY 2024) | 964.0% | Visakhapatnam, Andhra Pradesh, India | |||
| Sim Organics Private Limited | ₹30.92 Lakh (FY 2025) | -12.0% | Raipur, Chhattisgarh, India | |||
| Garima Calcium Products Private Limited | ₹30.89 Lakh (FY 2025) | 11.0% | Jaipur, Rajasthan, India | |||
| Lemoni Crop Care Private Limited | ₹30.87 Lakh (FY 2020) | Sayla, Gujarat, India | ||||
| Phagoo Pharma Private Limited | ₹30.86 Lakh (FY 2025) | 21.0% | New Delhi, Delhi, India |
To see the full peer comparison of Exotic Laboratories Pvt Ltd, buy the company report.
Shareholding
The shareholding of Exotic Laboratories Pvt Ltd is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Exotic Laboratories Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jul 2009 | 10174868 | Bank of Baroda | ₹80 Lakh | Satisfied | |
| 03 Oct 1994 | 90101512 | Bank of Baroda | ₹80 Lakh | Satisfied |
To see the full charge records of Exotic Laboratories Pvt Ltd, buy the company report.
Total charge records: 2 View all charges
Legal cases
Exotic Laboratories Pvt Ltd has 8 court cases on record: 6 filed by Exotic Laboratories, 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 2 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Vadodara, Gujarat | Court case (EXE SM) | Filed against the company by Ashwinbhai Choksi Prop. of Nikon Traders | Disposed |
| District court, Vadodara, Gujarat | Court case (SMST R) | Filed against the company by Nicon Traders | Disposed |
| District court, Vadodara, Gujarat | Court case (CR EN) | Filed by the company against an individual | Disposed |
| District court, Vadodara, Gujarat | Court case (CR EN) | Filed by the company against an individual | Disposed |
| District court, Vadodara, Gujarat | Court case (SPCS) | Filed by the company against R.K.Industries and 1 other | Disposed |
To see the full case history of Exotic Laboratories Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Exotic Laboratories Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Exotic Laboratories Pvt Ltd has a workforce of 5 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
GST
Exotic Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACE4125F1Z8 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Exotic Laboratories Pvt Ltd, buy the company report.
Recent activity
Exotic Laboratories Pvt Ltd has 8 board changes on record since 2014: 3 appointments and 5 cessations. The latest: Shilpica Girish Bakshi ceased to be Additional Director on 08 Sep 2020.
4 earlier events are in the company report.
Frequently asked questions
Exotic Laboratories is an active private limited company based in Vadodara, Gujarat, India. The company works in chemical products, within the chemicals industry. It was incorporated on 16 April 1993 (33+ years old) and is registered under CIN U24231GJ1993PTC019298.
Exotic Laboratories has 3 current directors:
- Dharmisthaben Janardan Pandya - Whole-Time Director
- Jaymit Girish Bakshi - Director
- Shilpica Girish Bakshi - Director
The latest financial statements of Exotic Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Exotic Laboratories is 24AAACE4125F1Z8, registered in Gujarat.
The CIN (Corporate Identification Number) of Exotic Laboratories is U24231GJ1993PTC019298. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Exotic Laboratories has 8 court cases on record: 6 filed by the company and 2 filed against it.
Exotic Laboratories was incorporated on 16 April 1993, making it 33+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Exotic Laboratories by revenue are Harmonic Cet Solutions Private Limited, Kontiki Chemicals and Pharmaceuticals Pvt Ltd, Guillain Pharma Private Limited, Biostategi (OPC) Private Limited, Valcambi Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Shilpica Girish Bakshi ceased to be Additional Director on 08 Sep 2020. Shilpica Girish Bakshi was appointed as Director on 24 Dec 2019. Jaymit Girish Bakshi ceased to be Additional Director on 29 Sep 2018. Exotic Laboratories has 8 board changes on record in total.
The registered office of Exotic Laboratories is at A – 1 Krishna Park Near. Mothers School Gotri, Vadodara, Gujarat, India – 390021.
Exotic Laboratories operates in the chemicals industry, in the chemical products segment.